Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $60.0 million.

  • Bio's Total Liabilities rose 125.15% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year increase of 125.15%. This contributed to the annual value of $58.1 million for FY2024, which is 178.31% down from last year.
  • Bio's Total Liabilities amounted to $60.0 million in Q3 2025, which was up 125.15% from $58.4 million recorded in Q2 2025.
  • Bio's 5-year Total Liabilities high stood at $60.0 million for Q3 2025, and its period low was $36.6 million during Q1 2021.
  • Over the past 5 years, Bio's median Total Liabilities value was $56.3 million (recorded in 2022), while the average stood at $52.8 million.
  • Per our database at Business Quant, Bio's Total Liabilities skyrocketed by 3695.72% in 2022 and then crashed by 178.31% in 2024.
  • Bio's Total Liabilities (Quarter) stood at $42.4 million in 2021, then grew by 26.16% to $53.6 million in 2022, then increased by 10.49% to $59.2 million in 2023, then dropped by 1.78% to $58.1 million in 2024, then rose by 3.3% to $60.0 million in 2025.
  • Its Total Liabilities was $60.0 million in Q3 2025, compared to $58.4 million in Q2 2025 and $59.1 million in Q1 2025.